reference/10855418

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10855418

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, N.I.H., Intramural
endingPage	1403
issn	1875-8908 1387-2877
issueIdentifier	4
pageRange	1391-1403
publicationName	Journal of Alzheimer's disease : JAD
startingPage	1391
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_148366c6977ae4cea121a214c26e4fcc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b53766736ed12354ccd9fa28dd3b5a6a
bibliographicCitation	Fremont R, Manoochehri M, Armstrong NM, Mattay VS, Apud JA, Tierney MC, Devanand DP, Gazes Y, Habeck C, Wassermann EM, Grafman J, Huey ED. Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study. J Alzheimers Dis. 2020;75(4):1391–403. PMID: 32444540; PMCID: PMC10131251.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f24fa45d942eb5553e0e4e7c5fcda87d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8c7356fbaafca0c81a50bee7ea8c537 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3654331b028c3561f7f71dbef885c1ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a45266a99ef767a382700e0cddf09f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bfe3e405a31447125ff1813584f268f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cd09866c29ba11beeca5f29fa7efb66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d86f4ad38dfc265abf96341b62ed007 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_669be3eaf445383466d8d0f84d14d9f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faa7819b594c0fc051231d60d066a9b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb1fe96e650182f3b58ca71c4e989a67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_487fd28a383872c923380eb5c4573684 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_053e65fd050489b91daa93d19eb7c14d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5285-7899
date	2020-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32444540 https://pubmed.ncbi.nlm.nih.gov/PMC10131251 https://doi.org/10.3233/jad-191265
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1387-2877 https://portal.issn.org/resource/ISSN/1875-8908
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study
discusses	http://id.nlm.nih.gov/mesh/M0182081 http://id.nlm.nih.gov/mesh/M0587310
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000077867Q000627 http://id.nlm.nih.gov/mesh/D065098Q000627 http://id.nlm.nih.gov/mesh/D057180Q000523 http://id.nlm.nih.gov/mesh/D057180Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D057180Q000150 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001526Q000188 http://id.nlm.nih.gov/mesh/D001921Q000187 http://id.nlm.nih.gov/mesh/D003071Q000187 http://id.nlm.nih.gov/mesh/D001921Q000000981 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D018592
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11231 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11228 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4659569 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_247ffeecb23de2fe2f08abecf230e799

Total number of triples: 62.